Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 26 of 47

Summary of Benefits: Post-traumatic Stress Disorder

Adjunctive treatment with risperidone reduces the symptoms of combat-related post-traumatic stress disorder (PTSD). The strength of evidence supporting this finding is moderate. As a treatment for abused women with PTSD, the evidence of benefits from risperidone is insufficient to determine an effect. The evidence for olanzapine and quetiapine is insufficient for analysis.